Winnergy Medical Past Earnings Performance
Past criteria checks 1/6
Winnergy Medical's earnings have been declining at an average annual rate of -4.7%, while the Healthcare industry saw earnings growing at 20.9% annually. Revenues have been growing at an average rate of 10.4% per year. Winnergy Medical's return on equity is 5.1%, and it has net margins of 4.8%.
Key information
-4.7%
Earnings growth rate
-42.2%
EPS growth rate
| Healthcare Industry Growth | 23.6% |
| Revenue growth rate | 10.4% |
| Return on equity | 5.1% |
| Net Margin | 4.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Winnergy Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 639 | 31 | 230 | 0 |
| 30 Sep 23 | 667 | 38 | 239 | 0 |
| 30 Jun 23 | 654 | 43 | 217 | 0 |
| 31 Mar 23 | 685 | 54 | 210 | 0 |
| 31 Dec 22 | 703 | 61 | 204 | 0 |
| 30 Sep 22 | 685 | 65 | 193 | 0 |
| 30 Jun 22 | 652 | 79 | 195 | 0 |
| 31 Mar 22 | 577 | 68 | 189 | 0 |
| 31 Dec 21 | 539 | 65 | 186 | 0 |
| 30 Sep 21 | 521 | 60 | 183 | 0 |
| 30 Jun 21 | 520 | 50 | 179 | 0 |
| 31 Mar 21 | 518 | 53 | 172 | 0 |
| 31 Dec 20 | 531 | 52 | 178 | 0 |
| 30 Sep 20 | 544 | 62 | 184 | 0 |
| 31 Dec 19 | 492 | 45 | 180 | 0 |
| 31 Dec 17 | 453 | -15 | 175 | 0 |
Quality Earnings: WINMED has high quality earnings.
Growing Profit Margin: WINMED's current net profit margins (4.8%) are lower than last year (8.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: WINMED's earnings have declined by 4.7% per year over the past 5 years.
Accelerating Growth: WINMED's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: WINMED had negative earnings growth (-49.5%) over the past year, making it difficult to compare to the Healthcare industry average (-29.6%).
Return on Equity
High ROE: WINMED's Return on Equity (5.1%) is considered low.